Dent Neurologic Institute Amherst

Amherst, New York 14226-1727

2 studies enrolling now · 10 studies all time

What they study most

AChR-Ab Seropositive Generalized Myasthenia Gravis, Chronic Cluster Headache, Cluster Headache, Episodic, Early Parkinson Disease, Generalized Myasthenia Gravis, Generalized Myasthenia Gravis (gMG), MG, MMN, Medication Overuse Headache, Migraine, Multifocal Motor Neuropathy (MMN), Myasthenia Gravis

Studies at this site

• ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis — Recruiting now
• ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod — Recruiting now
• A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy — Running, not enrolling
• A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache — Completed
• PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706 — Stopped early
• Eptinezumab in Participants With Episodic Cluster Headache — Completed
• A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH) — Completed
• Real World Effectiveness of Eptinezumab in Participants With Migraine — Stopped early
• A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments — Completed
• A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine — Completed